Federal Register / Vol. 75, No. 202 / Wednesday, October 20, 2010 / Notices 64733 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of 

respondent 

Form 

name 

Number of 

respondents 

Number 

responses 

per 

respondent 

Average 

burden per 

response 

(in hrs) 

General Callers .................................... Brief Interactive Voice Response Survey (English & 

Spanish).

92,000 1 4/60 

Email Inquirers ..................................... Web Survey for E-mail Inquires (English & Spanish) .. 1,460 1 3/60 

Dated: October 14, 2010. 

Carol E. Walker, 

Acting Reports Clear Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2010–26386 Filed 10–19–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2010–F–0537] 

Arcadia Biosciences, Inc.; Filing of 

Food Additive Petition (Animal Use); 

Safflower Seed Meal 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that Arcadia Biosciences, Inc., has filed 

a petition proposing that the food 

additive regulations be amended to 

provide for the safe use of seed meal 

from a variety of bioengineered 

safflower in cattle and poultry feeds. 

DATES: Submit either electronic or 

written comments on the petitioner’s 

environmental assessment by November 

19, 2010. 

ADDRESSES: Submit electronic 

comments to: http:// 

www.regulations.gov. Submit written 

comments to the Division of Dockets 

Management (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, rm. 

1061, Rockville, MD 20852. 

FOR FURTHER INFORMATION CONTACT: 

Isabel W. Pocurull, Center for Veterinary 

Medicine, Food and Drug 

Administration, 7519 Standish Pl., 

Rockville, MD 20855, 240–453–6853, email: isabel.pocurull@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Federal Food, Drug, and Cosmetic Act 

(section 409(b)(5) (21 U.S.C. 348(b)(5))), 

notice is given that a food additive 

petition (FAP 2267) has been filed by 

Arcadia Biosciences, Inc., 202 Cousteau 

Pl., suite 105, Davis, CA 95618. The 

petition proposes to amend the food 

additive regulations in part 573 Food 

Additives Permitted in Feed and 

Drinking Water of Animals (21 CFR part 

573) to provide for the safe use of seed 

meal from a variety of bioengineered 

safflower (Carthamus tinctorius L.) in 

cattle and poultry feeds. The safflower 

variety has been bioengineered to 

contain a gene from the water mold 

Saprolegnia diclina responsible for 

production of g-linolenic acid in the 

seed oil. Seed meals are the ground 

residues obtained after processing seeds 

to extract their oil and are a common 

ingredient in livestock feed. 

The potential environmental impact 

of this action is being reviewed. To 

encourage public participation 

consistent with regulations issued under 

the National Environmental Policy Act 

(40 CFR 1501.4(b)), the agency is 

placing the environmental assessment 

submitted with the petition that is the 

subject of this notice on public display 

at the Division of Dockets Management 

(see DATES and ADDRESSES) for public 

review and comment. 

Interested persons may submit to the 

Division of Dockets Management (see 

ADDRESSES) either electronic or written 

comments regarding this document. It is 

only necessary to send one set of 

comments. It is no longer necessary to 

send two copies of mailed comments. 

Identify comments with the docket 

number found in brackets in the 

heading of this document. Received 

comments may be seen in the Division 

of Dockets Management between 9 a.m. 

and 4 p.m., Monday through Friday. 

FDA will also place on public display 

any amendments to, or comments on, 

the petitioner’s environmental 

assessment without further 

announcement in the Federal Register. 

If, based on its review, the agency finds 

that an environmental impact statement 

is not required and this petition results 

in a regulation, the notice of availability 

of the agency’s finding of no significant 

impact and the evidence supporting that 

finding will be published with the 

regulation in the Federal Register in 

accordance with 21 CFR 25.51(b). 

Dated: October 14, 2010. 

William T. Flynn, 

Acting Director, Center for Veterinary 

Medicine. 

[FR Doc. 2010–26345 Filed 10–19–10; 8:45 am] 

BILLING CODE 4160–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Alcohol Abuse 

and Alcoholism; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 USC, 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable materials, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism, Special 

Emphasis Panel, NIAAA Member Conflict 

Applications. 

Date: October 26, 2010. 

Time: 11 a.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 5635 

Fishers Lane, Bethesda, MD 20892. 

(Telephone Conference Call) 

Contact Person: Ranga Srinivas, PhD, 

Chief, Extramural Project Review Branch, 

EPRB, National Institute on Alcohol Abuse 

and Alcoholism, National Institutes of 

Health, 5635 Fishers Lane, Room 2085, 

Bethesda, MD 20892. 301–451–2067. 

srinivar@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.271, Alcohol Research 

Career Development Awards for Scientists 

and Clinicians; 93.272, Alcohol National 

Research Service Awards for Research 

Training; 93.273, Alcohol Research Programs; 

93.891, Alcohol Research Center Grants; 

93.701, ARRA Related Biomedical Research 


emcdonald on DSK2BSOYB1PROD with NOTICES